These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 18215598)
1. Impaired fasting glucose and outcomes of ST-elevation acute coronary syndrome treated with primary percutaneous intervention among patients without previously known diabetes mellitus. Porter A; Assali AR; Zahalka A; Iakobishvili Z; Brosh D; Lev EI; Mager A; Battler A; Kornowski R; Hasdai D Am Heart J; 2008 Feb; 155(2):284-9. PubMed ID: 18215598 [TBL] [Abstract][Full Text] [Related]
2. Comparison of myocardial reperfusion in patients with fasting blood glucose < or =100, 101 to 125, and >125 mg/dl and ST-elevation myocardial infarction with percutaneous coronary intervention. Fefer P; Hod H; Ilany J; Shechter M; Segev A; Novikov I; Guetta V; Matetzky S Am J Cardiol; 2008 Dec; 102(11):1457-62. PubMed ID: 19026295 [TBL] [Abstract][Full Text] [Related]
3. Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: the Global Registry of Acute Coronary Events. Sinnaeve PR; Steg PG; Fox KA; Van de Werf F; Montalescot G; Granger CB; Knobel E; Anderson FA; Dabbous OH; Avezum A; Arch Intern Med; 2009 Feb; 169(4):402-9. PubMed ID: 19237725 [TBL] [Abstract][Full Text] [Related]
5. Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention. Muhlestein JB; Anderson JL; Horne BD; Lavasani F; Allen Maycock CA; Bair TL; Pearson RR; Carlquist JF; Am Heart J; 2003 Aug; 146(2):351-8. PubMed ID: 12891207 [TBL] [Abstract][Full Text] [Related]
6. Does glucose level at hospital discharge predict one-year mortality in patients with diabetes mellitus treated with percutaneous coronary intervention for ST-segment elevation myocardial infarction? Gasior M; Pres D; Stasik-Pres G; Lech P; Gierlotka M; Lekston A; Hawranek M; Tajstra M; Kalarus Z; Poloński L Kardiol Pol; 2008 Jan; 66(1):1-8; discussion 9-11. PubMed ID: 18266182 [TBL] [Abstract][Full Text] [Related]
7. Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study. Suleiman M; Hammerman H; Boulos M; Kapeliovich MR; Suleiman A; Agmon Y; Markiewicz W; Aronson D Circulation; 2005 Feb; 111(6):754-60. PubMed ID: 15699267 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of admission glucose in non-diabetic patients with myocardial infarction. Timmer JR; van der Horst IC; Ottervanger JP; Henriques JP; Hoorntje JC; de Boer MJ; Suryapranata H; Zijlstra F; Am Heart J; 2004 Sep; 148(3):399-404. PubMed ID: 15389225 [TBL] [Abstract][Full Text] [Related]
9. Relationship between blood glucose on admission and prognosis in patients with acute myocardial infarction treated with percutaneous coronary intervention. Gasior M; Stasik-Pres G; Pres D; Lech P; Gierlotka M; Lekston A; Hawranek M; Tajstra M; Kalarus Z; Poloński L Kardiol Pol; 2007 Sep; 65(9):1031-8; discussion 1039-40. PubMed ID: 17975750 [TBL] [Abstract][Full Text] [Related]
10. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Buller CE; Fu Y; Mahaffey KW; Todaro TG; Adams P; Westerhout CM; White HD; van 't Hof AW; Van de Werf FJ; Wagner GS; Granger CB; Armstrong PW Circulation; 2008 Sep; 118(13):1335-46. PubMed ID: 18779444 [TBL] [Abstract][Full Text] [Related]
11. Impact of admission blood glucose on outcomes of nondiabetic patients with acute ST-elevation myocardial infarction (from the German Acute Coronary Syndromes [ACOS] Registry). Naber CK; Mehta RH; Jünger C; Zeymer U; Wienbergen H; Sabin GV; Erbel R; Senges J; Gitt A Am J Cardiol; 2009 Mar; 103(5):583-7. PubMed ID: 19231316 [TBL] [Abstract][Full Text] [Related]
12. Serum glucose levels and hospital outcomes in patients with acute myocardial infarction without prior diabetes: a community-wide perspective. Goldberg RJ; Kramer DG; Lessard D; Yarzebski J; Gore JM Coron Artery Dis; 2007 Mar; 18(2):125-31. PubMed ID: 17301604 [TBL] [Abstract][Full Text] [Related]
13. Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial infarction (FAST-MI). Danchin N; Coste P; Ferrières J; Steg PG; Cottin Y; Blanchard D; Belle L; Ritz B; Kirkorian G; Angioi M; Sans P; Charbonnier B; Eltchaninoff H; Guéret P; Khalife K; Asseman P; Puel J; Goldstein P; Cambou JP; Simon T; Circulation; 2008 Jul; 118(3):268-76. PubMed ID: 18591434 [TBL] [Abstract][Full Text] [Related]
14. [Prognostic value of first fasting glucose measurement compared with admission glucose level in patients with acute coronary syndrome]. Vivas D; García-Rubira JC; González-Ferrer JJ; Núñez-Gil I; del Prado N; Fernández-Ortiz A; Macaya C Rev Esp Cardiol; 2008 May; 61(5):458-64. PubMed ID: 18462648 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of impaired fasting glucose for outcomes of patients with stable angina pectoris treated with percutaneous coronary interventions. Dibra A; Ndrepepa G; Mehilli J; Pineck S; Mayer S; Bollwein H; Hausleiter J; Pache J; Schömig A; Kastrati A Am J Cardiol; 2005 Oct; 96(8):1113-5. PubMed ID: 16214448 [TBL] [Abstract][Full Text] [Related]
16. Risk stratification according to the type of impaired renal function in patients with acute myocardial infarction treated with percutaneous coronary intervention. Kowalczyk J; Lenarczyk R; Kowalski O; Swiatkowski A; Stabryła-Deska J; Kurek T; Honisz G; Kukulski T; Gasior M; Kalarus Z Kardiol Pol; 2007 Jun; 65(6):635-43; discussion 644. PubMed ID: 17629825 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of admission fasting glucose levels in patients with acute coronary syndrome. Kolman L; Hu YC; Montgomery DG; Gordon K; Eagle KA; Jackson EA Am J Cardiol; 2009 Aug; 104(4):470-4. PubMed ID: 19660596 [TBL] [Abstract][Full Text] [Related]
18. Usefulness of changes in fasting glucose during hospitalization to predict long-term mortality in patients with acute myocardial infarction. Aronson D; Hammerman H; Suleiman M; Markiewicz W Am J Cardiol; 2009 Oct; 104(8):1013-7. PubMed ID: 19801016 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of kidney function in patients with ST-elevation and non-ST-elevation acute myocardial infarction treated with percutaneous coronary intervention. Seyfarth M; Kastrati A; Mann JF; Ndrepepa G; Byrne RA; Schulz S; Mehilli J; Schömig A Am J Kidney Dis; 2009 Nov; 54(5):830-9. PubMed ID: 19592145 [TBL] [Abstract][Full Text] [Related]
20. Hyperglycemia during acute myocardial infarction in patients who are treated by primary percutaneous coronary intervention: impact on long-term prognosis. Lavi S; Kapeliovich M; Gruberg L; Roguin A; Boulos M; Grenadier E; Amikam S; Markiewicz W; Beyar R; Hammerman H Int J Cardiol; 2008 Jan; 123(2):117-22. PubMed ID: 17367882 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]